Chemotargets offers validated and cutting-edge computational methodologies with top market predictive performance. The innovation strategy of the company is driven by new computational methods and strategies directed by Dr. Mestres.
Chemotargets’ goal is to help the biopharma industry fast-forward the process of bringing new medicines to market, speeding up drug discovery and development programs, and improving cost-efficiency and safety.
“Chemotargets offers validated and cutting-edge computational methodologies with top market predictive performance. The innovation strategy of the company is driven by our will to develop a fully integrated platform capable of generating novel drug candidates”
Dr. Jordi Mestres
Founder
“Our goal is to help the biopharma industry fast-forward the process of bringing new medicines to market, speeding up drug discovery and development programs, and improving cost-efficiency and safety.”
Dr. Scott Boyer
CEO
Our Team
We are a multidisciplinary team of more than 40 computational biologists, chemists, data scientists, model building professionals and software developers.
